EMA Authorised: Zoledronic acid Mylan (zoledronic acid) — Mylan Pharmaceuticals Limited

View source ↗

Summary

The European Medicines Agency authorised Zoledronic acid Mylan (zoledronic acid) for bone/fracture indications. The product is manufactured by Mylan Pharmaceuti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Zoledronic acid Mylan (zoledronic acid)

Snippet

Status: Authorised. Therapeutic area: Fractures, Bone. MAH: Mylan Pharmaceuticals Limited. Decision date: 31/03/2026